I-Mab P/E Ratio

I-Mab's p/e ratio stands at -22.85. That is below the Healthcare sector average of 26.85. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

I-Mab sits lower the Healthcare benchmark (26.85) with a P/E ratio of -22.85. That is roughly 185.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether -22.85 is attractive depends on I-Mab's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how I-Mab's P/E ratio evolved across reporting periods, while the comparison chart places IMAB next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, P/E ratio is commonly used to spot outliers. I-Mab's reading of -22.85 (sector avg 26.85) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.